The implications of outcome truncation in reproductive medicine RCTs: a simulation platform for trialists and simulation study
Jack Wilkinson, Jonathan Huang, Antonia Marsden, Michael Harhay, Andy, Vail, Stephen A Roberts

TL;DR
This study introduces a simulation platform to assess how outcome truncation affects the validity of statistical analyses in reproductive medicine RCTs, revealing potential biases and issues in inference.
Contribution
The paper presents a novel simulation tool to evaluate the impact of outcome truncation on statistical inference in reproductive medicine trials.
Findings
Outcome truncation can bias estimates and affect error rates.
Binary outcomes may lead to no observed events in one arm, impacting analysis.
Adverse effects are generally moderate within realistic parameters.
Abstract
Randomised controlled trials in reproductive medicine are often subject to outcome truncation, where study outcomes are only defined in a subset of participants. Examples include birthweight (measurable only in the subgroup of participants who give birth) and miscarriage (which can only occur in participants who become pregnant). These are typically analysed by making a comparison between treatment arms within the subgroup (comparing birthweights in the subgroup who gave birth, or miscarriages in the subgroup who became pregnant). However, this approach does not represent a randomised comparison when treatment influences the probability of being observed (i.e. survival). The practical implications of this for reproductive trials are unclear. We developed a simulation platform to investigate the implications of outcome truncation for reproductive medicine trials. We used this to perform…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
